Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negatives-Reference-Cited by-同舟云学术

Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives

Published:2024-08-27 Issue: Volume: Page:1-8
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Lee Ikjae¹,Garret Mark A.²,Wuu Joanne³,Harrington Elizabeth A.¹,Berry James D.²,Miller Timothy M.⁴,Harms Matthew¹,Benatar Michael³,Shneider Neil¹

Affiliation:

1. Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA

2. Sean M. Healey & AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

3. Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA

4. Department of Neurology, Washington University, St. Louis, MO, USA

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678421.2024.2396831

Reference31 articles.

1. Amyotrophic lateral sclerosis;Rowland LP;N Engl J Med,2001

2. Amyotrophic lateral sclerosis: an update for 2018;Oskarsson B;Mayo Clin Proc,2018

3. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications;Chia R;Lancet Neurol,2018

4. Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers;Dorst J;Ebiomedicine,2023

5. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study;Westeneng HJ;Lancet Neurol,2021